AU6167696A - Preparation of immunogens and other conjugates of drugs - Google Patents

Preparation of immunogens and other conjugates of drugs

Info

Publication number
AU6167696A
AU6167696A AU61676/96A AU6167696A AU6167696A AU 6167696 A AU6167696 A AU 6167696A AU 61676/96 A AU61676/96 A AU 61676/96A AU 6167696 A AU6167696 A AU 6167696A AU 6167696 A AU6167696 A AU 6167696A
Authority
AU
Australia
Prior art keywords
immunogens
conjugates
drugs
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61676/96A
Inventor
Hon-Peng Phillip Lau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dade Chemistry Systems Inc
Original Assignee
Dade Chemistry Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Chemistry Systems Inc filed Critical Dade Chemistry Systems Inc
Publication of AU6167696A publication Critical patent/AU6167696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
AU61676/96A 1995-06-07 1996-06-07 Preparation of immunogens and other conjugates of drugs Abandoned AU6167696A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US473382 1983-03-08
US47338295A 1995-06-07 1995-06-07
PCT/US1996/009834 WO1996040664A2 (en) 1995-06-07 1996-06-07 Preparation of immunogens and other conjugates of drugs

Publications (1)

Publication Number Publication Date
AU6167696A true AU6167696A (en) 1996-12-30

Family

ID=23879302

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61676/96A Abandoned AU6167696A (en) 1995-06-07 1996-06-07 Preparation of immunogens and other conjugates of drugs

Country Status (4)

Country Link
EP (1) EP0775128A1 (en)
JP (1) JPH10504324A (en)
AU (1) AU6167696A (en)
WO (1) WO1996040664A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6570016B1 (en) * 1999-06-03 2003-05-27 Eli Lilly And Company Process for preparing a 10,11-methanodibenzosuberane derivative
SE0002531D0 (en) * 2000-07-05 2000-07-05 Active Biotech Ab Immune Enhancement
DE60327765D1 (en) 2002-06-24 2009-07-09 Janssen Pharmaceutica Nv PROCESS FOR PREPARING N- (2,6-DIMETHYLPHENYL) -2-PIPERAZINE-1-YLACETAMIDE
WO2010023687A2 (en) * 2008-08-28 2010-03-04 Shodhana Laboratories Limited Preparation of ranolazine, its salts and intermediates thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3349128A (en) * 1965-06-28 1967-10-24 Colgate Palmolive Co Production of omicron-(monoalkyl aminoalkyl) oximes of dibenzo-[a, d] cyclohepten-5-ones
CA875549A (en) * 1968-12-03 1971-07-13 Ayerst, Mckenna And Harrison Limited Process for preparing amitriptyline and related compounds
CH541545A (en) * 1970-10-09 1973-09-15 Hoffmann La Roche Process for the preparation of tricyclic imines
FR2350100A1 (en) * 1976-05-06 1977-12-02 Sauba Lab DISUBSTITUTE DERIVATIVES OF PIPERAZINE, THEIR PROCESS FOR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS
US4567264A (en) * 1983-05-18 1986-01-28 Syntex (U.S.A.) Inc. Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry
US4558129A (en) * 1983-05-18 1985-12-10 Syntex (U.S.A.) Inc. Benzodioxanyl-hydroxyethylene-piperazinyl acetanilides which effect calcium entry and β-blockade
FR2601366B1 (en) * 1986-07-10 1988-11-25 Andre Buzas BENZHYDRYLOXYETHYL-PIPERAZINE DERIVATIVES, PROCESSES FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
EP0582164B1 (en) * 1992-07-31 1998-12-23 Bristol-Myers Squibb Company Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles

Also Published As

Publication number Publication date
WO1996040664A2 (en) 1996-12-19
WO1996040664A3 (en) 1997-03-13
JPH10504324A (en) 1998-04-28
EP0775128A1 (en) 1997-05-28

Similar Documents

Publication Publication Date Title
AU6046396A (en) Tricot-like pouch for the delivery of topical drugs and cosm etics
AU7572196A (en) Pharmaceutical formulations
AUPN411195A0 (en) Medicinal composition
AU7590096A (en) Drug composition
IL118294A0 (en) Preparation of 4-aryl-piperidine derivatives
AU7294196A (en) Stable pharmaceutical forms of administration containing parathormone
AU4981896A (en) Liposome composition and method for administering liposome-loadable drugs
PL314637A1 (en) Adjuvant drug with derivatives of paklitaxel
AU6517396A (en) Preparation of N-substituted 3-hydroxypyrazoles
AU6015796A (en) Fused imidazole derivatives and medicinal composition thereof
AU4843996A (en) Imidazole derivatives and medicinal composition thereof
AU4458996A (en) Ethylamine derivatives and drugs
GB9601186D0 (en) Administration of Drugs
AU6167696A (en) Preparation of immunogens and other conjugates of drugs
AU5347996A (en) Preparation for oral administration
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU1475595A (en) Pharmaceutical preparation
AU7000496A (en) Anti-inflammatory antisense drug
AP9801196A0 (en) Pharmaceutical preparation
AU3710695A (en) Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them
AU1036097A (en) 5-Naphthalen-1-yl-1,3-dioxane derivatives, their preparation and their therapeutic application
AU7551896A (en) 1-azabicycloheptane derivatives and their pharmaceutical use
AU6171196A (en) Therapeutic uses of ta99
AU1195597A (en) Dibenzothiepin derivatives and pharmaceutical compositions
AU6298196A (en) Tetrahydro-betacarboline derivatives and their preparation and use